Taiyuan Market Supervision Administration Advances the Implementation of Unique Device Identification (UDI) for Medical Devices

Deep News
Oct 17, 2025

On October 14, the Taiyuan Market Supervision Administration held a seminar on the implementation of Unique Device Identification (UDI) for medical devices in the city. The meeting aimed to implement the directives from the National Medical Products Administration and the Provincial Medical Products Administration, review the progress of UDI implementation across the city, and address challenges encountered during the process. Over 20 participants from the Administration’s medical device regulation department, relevant medical institutions, and medical device companies attended the meeting.

The meeting focused on interpreting the core value of UDI as a "digital identity card" for medical devices. It systematically conveyed the work requirements regarding UDI implementation from the National and Provincial Medical Products Administrations and reported on the results of a preliminary survey regarding UDI implementation in the city. Representatives from attending units reported on their respective UDI implementation progress and engaged in in-depth discussions about key issues encountered, such as the lack of unified coding standards, incompatible system interfaces, high data integration costs, poor integration with health insurance codes, and unfamiliarity of staff with operational procedures.

The meeting emphasized that all units should prioritize UDI implementation, concentrating efforts on key areas such as information system renovation, hardware and software upgrades, and data integration to drive the informatization of medical device traceability. It called for strengthened collaboration and coordination, establishing platforms for communication between medical institutions and companies. By synchronizing online and offline interactions and regularly sharing information, the aim is to collaboratively address and efficiently resolve challenges. Furthermore, it urged enhanced supervision and proactive service to orderly promote the implementation of precise traceability regulatory measures throughout the entire lifecycle of medical devices, ensuring the safety of devices used by the public.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10